Amphetamine Patent Expiration
Amphetamine was first introduced by Neos Therapeutics
Amphetamine Patents
Given below is the list of patents protecting Amphetamine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Adzenys Er | US8709491 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps Inc |
| Adzenys Er | US9017731 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps Inc |
| Adzenys Er | US9265737 | Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles | Jun 28, 2032 | Neos Theraps Inc |
| Adzenys Xr-odt | US8709491 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps |
| Adzenys Xr-odt | US9017731 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps |
| Adzenys Xr-odt | US9265737 | Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles | Jun 28, 2032 | Neos Theraps |
| Adzenys Xr-odt | US9839619 | Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles | Jun 28, 2032 | Neos Theraps |
| Adzenys Xr-odt | US8840924 | Compositions and methods of making rapidly dissolving ionically masked formulations | Apr 09, 2026 | Neos Theraps |
Amphetamine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List